NEU 2.50% $15.59 neuren pharmaceuticals limited

ROW Rights, page-102

  1. 3,259 Posts.
    lightbulb Created with Sketch. 7135
    And further to those thoughts, it would be expected after the last year of negotiations and collaborations, that ACAD would have a good understanding of what Treagus would expect out of a deal.

    I doubt many of will live Long enough to see NEU develop 2591, at the pace they move.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.